Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients
The heterogeneous nature of inflammatory bowel disease (IBD) presents challenges, particularly when choosing therapy. Activation of the NF-κB transcription factor is a highly regulated, dynamic event in IBD pathogenesis. Using a lentivirus approach, NF-κB-regulated luciferase was expressed in patient macrophages, isolated from frozen peripheral blood mononuclear cell samples. Following activation, samples could be segregated into three clusters based on the NF-κB-regulated luciferase response. The ulcerative colitis (UC) samples appeared only in the hypo-responsive Cluster 1, and in Cluster 2. Conversely, Crohn's disease (CD) patients appeared in all Clusters with their percentage being higher in the hyper-responsive Cluster 3. A positive correlation was seen between NF-κB-induced luciferase activity and the concentrations of cytokines released into medium from stimulated macrophages, but not with serum or biopsy cytokine levels. Confocal imaging of lentivirally-expressed p65 activation revealed that a higher proportion of macrophages from CD patients responded to endotoxin lipid A compared to controls. In contrast, cells from UC patients exhibited a shorter duration of NF-κB p65 subunit nuclear localization compared to healthy controls, and CD donors. Analysis of macrophage cytokine responses and patient metadata revealed a strong correlation between CD patients who smoked and hyper-activation of p65. These in vitro dynamic assays of NF-κB activation in blood-derived macrophages have the potential to segregate IBD patients into groups with different phenotypes and may therefore help determine response to therapy.
CITE THIS COLLECTION
REFERENCES
- https://doi.org//10.1007/BF01300378
- https://doi.org//10.1053/j.gastro.2011.02.016
- https://doi.org//10.1101/gad.183434.111
- https://doi.org//10.1126/science.1164860
- https://doi.org//10.1126/scisignal.2004764
- https://doi.org//10.1038/nature09145
- https://doi.org//10.1016/j.cell.2015.01.013
- https://doi.org//10.1038/ncomms12057
- https://doi.org//10.1126/scisignal.aaf3998
- https://doi.org//10.1126/scisignal.aaa5208
- https://doi.org//10.1111/j.1365-2796.2008.01953.x
- https://doi.org//10.1111/j.1749-6632.1998.tb11119.x
- https://doi.org//10.1016/S0016-5085(98)70202-1
- https://doi.org//10.1136/gut.52.10.1448
SHARE
Usage metrics
Read the peer-reviewed publication
AUTHORS (16)
CATEGORIES
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity